MedTrace Logo

Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)

NCT02333851 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2015-01-07

No results posted yet for this study

Summary

Pilot study to compare the efficacy and safety of a premixed-insulin regimen (70% intermediate insulin and 30% regular insulin) to a basal-bolus insulin regimen (glargine once daily and glulisine before meals) hospitalized patients with type 2 diabetes.

Conditions

Interventions

DRUG

Mixtard 30:70 Novonordisk® twice daily

Premixed insulin twice daily before breakfast and before dinner

DRUG

Lantus® once daily and Apidra® before meals

Injection of Lantus® insulin once daily and rapid insulin Apidra® before breakfast, lunch and dinner

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Hospital Universitario Central de Asturias

    lead OTHER

Principal Investigators

  • Edelmiro Menéndez Torre · Hospital Universitario Central de Asturias

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-02-28
Completion
2014-02-28

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02333851 on ClinicalTrials.gov